Cambridge Consultants Offers Fast Track to Phase I Clinical Trials for Inhalable Drugs with Development Support for Conix

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Cambridge Consultants (www.cambridgeconsultants.com) is demonstrating a series of technology developments and services for its Conix inhalable drug delivery technology at the upcoming Respiratory Drug Delivery Conference in Scottsdale, Ariz., for companies looking to accelerate their move into Phase I clinical trials for their inhalable drugs. Conix offers a low cost threshold previously not available with traditional inhaler technology developments.

MORE ON THIS TOPIC